This is the authors' abstract. We don't add key points for this paper.
This study provides a proof of principle that some key diagnosis-related contraindications can be identified based on a patient's medication data alone, while others cannot be identified. This approach offers new opportunities to analyse drug-disease contraindications in community pharmacy or clinical routine data.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Andrikyan et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: